Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study | HTML
Event-free survival, cumulative incidence of relapse and overall... | Download Scientific Diagram
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy | Haematologica
A) Overall survival and (B) event-free survival of 58 patients with... | Download Scientific Diagram
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE
Overall survival and event-free survival according to primary... | Download Scientific Diagram
The 5-year Kaplan-Meier overall survival (K-M OS) (A) and event-free... | Download Scientific Diagram
Outcome (overall survival, OS blue, and event-free survival, EFS red)... | Download Scientific Diagram
Treatment of Acute Lymphoblastic Leukemia | NEJM
Event-free survival (EFS) of patients with acute promylocytic leukemia... | Download Scientific Diagram
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram
Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia | Leukemia
Interpretation of clinical endpoints in trials of acute myeloid leukemia - ScienceDirect
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor - Clinical Lymphoma, Myeloma and Leukemia
